Company profile

Evosep company profile

Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster. They are targeting the growing need for throughput with robust solutions for clinical and large-scale proteomics, and they have a very ambitious business plan to bring their first products to market. They are basing their design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis. Evosep aims to improve quality of life and patient care by radically innovating how protein based clinical diagnostics are performed, initially through collaborations with..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00051-00100 employees
Revenue range
$1K+
Founded
2016-01-01

Headquarters

Headquarters
Denmark, Odense, Syddanmark
Postal code
DK-5000
Country code
DK
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
2
Total equity funding
$40M
Last funding
Series Unknown / $40M / 2023-01-09
Last equity funding
Series Unknown / $40M
Investors
2
Lead investors
1
Founders
1
Articles
36
Exited on
2025-11-18

Founders and investors

Founders

Ole Vorm

Lead investors

Novo Holdings

Investors

Novo HoldingsVaekstfonden

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.